In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tallying Up the Dx Score Card

Executive Summary

An overview of the diagnostics industry's year-to-date performance is not inspiring. Total industry sales are expected to be down 2-3% this year from last year, analysts say. The top eight diagnostics companies have an increasing percentage of the business. Hardest hit were immunoassay and clinical chemistry segments; best-performers were nucleic acid probes and diabetes care.

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

IV000829

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel